Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

Cleo L. Crunelle, Elsmarieke van de Giessen, Sybille Schulz, Louk J. M. J. Vanderschuren, Kora de Bruin, Wim van den Brink, Jan Booij

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)908-911
JournalAddiction Biology
Volume18
Issue number6
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Cannabinoid 1 receptor
  • dopamine D2 receptor
  • IBZM
  • nucleus accumbens
  • rimonabant
  • striatum

Cite this